Citation: Aw. Lyon et al., USE OF THROMBIN INHIBITORS EX-VIVO ALLOWS CRITICAL CARE CLINICAL-CHEMISTRY AND HEMATOLOGY TESTING ON COMMON SPECIMENS, Clinical biochemistry, 30(2), 1997, pp. 121-127
Citation: Dw. Drobot et al., USE OF A THROMBIN INHIBITOR D-PHENYLALANYL-L-PROLYL-L-ARGININE CHLOROMETHYL KETONE (PPACK), WITH A FACTOR-XA INHIBITOR, 1,5-DANSYL-L-GLUTAMYL-L-GLYCYL-L-ARGININE CHLOROMETHYL KETONE (GGACK) FOR ANTICOAGULATIONOF CLINICAL-CHEMISTRY SPECIMENS, Clinical chemistry, 42(6), 1996, pp. 757-757
Citation: Aw. Lyon et al., EVALUATION OF CONCORD(R) CALCIUM NEUTRALIZED DRY LITHIUM HEPARIN PRO-VENT(TM) BLOOD-GAS SYRINGES FOR DETERMINATION OF BLOOD-GASES, ELECTROLYTES AND IONIZED CALCIUM, Clinical chemistry, 42(6), 1996, pp. 762-762
Citation: Sr. Harding et al., THE USE OF THE DIRECT THROMBIN INHIBITOR D-PHENYLALANYL-L-PROLYL-L-ARGININE CHLOROMETHYLKETONE (PPACK) FOR THE PRESERVATION OF BONE-MARROW ASPIRATES FOR FLOW-CYTOMETRY, Blood, 88(10), 1996, pp. 2991-2991
Authors:
BRIGDEN MAM
BORMANIS BJ
CRUICKSHANK M
GEERTS W
GILES A
HIRSH J
HULL R
JOHNSON J
JOHNSTON M
LECLERC J
MANT M
PINEO G
ROBINSON S
ROBITAILLE D
HARDING SR
SCULLY MF
TURPIE AG
VICKARS L
WHITMAN L
Citation: Mam. Brigden et al., INR REPORTING IN CANADIAN MEDICAL LABORATORIES, American journal of hematology, 48(4), 1995, pp. 237-239
Authors:
POBEDIMSKAYA DD
MOLCHANOVA TP
HUISMAN THJ
HARDING SR
BAKANEC R
Citation: Dd. Pobedimskaya et al., HB F-SASKATOON OR ALPHA(2)(G)GAMMA(2)21(B3)GLU-]LYS OBSERVED IN A NORTH-AMERICAN INDIAN NEWBORN, Hemoglobin, 17(6), 1993, pp. 547-549
Citation: A. Kirk et Sr. Harding, CARDIOEMBOLIC CAUDATE INFARCTION AS A CAUSE OF HEMICHOREA IN LUPUS ANTICOAGULANT SYNDROME, Canadian journal of neurological sciences, 20(2), 1993, pp. 162-164